Mouth and throat cancers are highly treatable if caught early, but they are often diagnosed at later stages because people ...

A man from Eloy has become the first rattlesnake bite case treated by Banner Health in 2025. Officials with the health system ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...

These doctors do NOT deserve their lab coats. The study reveals new evidence that reinforces the health consequences of ...

Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging ...

GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

Some brand name GLP-1s include Ozempic and Trulicity — though Winfrey hasn't revealed a specific brand. "One of the things that I realized the very first time I took a GLP-1 was that all these ...